No Data
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market?
Abbott Laboratories Analyst Ratings
Piper Sandler Initiates Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $131
Piper Sandler analyst Adam Maeder initiates coverage on $Abbott Laboratories(ABT.US)$ with a buy rating, and sets the target price at $131.According to TipRanks data, the analyst has a success rate
Buy Rating on Abbott Laboratories: Undervalued With Strong Growth Prospects Despite NEC Litigation
Express News | Abbott : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $131